{
  "context": {
    "cell_type": "malignant glioblastoma cells",
    "disease": "glioblastoma",
    "tissue": "brain"
  },
  "input_genes": [
    "SERPINE1",
    "EMP1",
    "SPOCD1",
    "ARHGAP29",
    "IL1R1",
    "COL6A2",
    "MYOF",
    "F13A1",
    "CXCL10",
    "CHI3L1",
    "MET",
    "IL6",
    "SAA2",
    "BIRC3",
    "MCTP2",
    "ANGPTL4",
    "ICAM1",
    "CCN1",
    "CAV1",
    "APLN",
    "FOSL1",
    "SNTG2-AS1",
    "TPD52L1",
    "SAA4",
    "KRT75",
    "NFATC2",
    "COL5A1",
    "AC243829.2",
    "CLCF1",
    "ARSJ",
    "PLA2G2A",
    "HMGA2",
    "PTX3",
    "TLR2",
    "LINC00698",
    "ALPK2",
    "TNFAIP3",
    "TNFAIP2",
    "NDRG1",
    "SMOC2",
    "ADGRL2",
    "KANK4",
    "GEM",
    "FAS",
    "CXCL8",
    "CFH",
    "ABCC3",
    "CXCL14",
    "ZFP36",
    "RCAN2",
    "GADD45A",
    "COL1A2",
    "LTF",
    "DHRS3",
    "IDO1",
    "HAP1",
    "AXL",
    "ATP6V0D2",
    "KLF5",
    "ST6GALNAC5",
    "GPD1",
    "PAPPA2",
    "BAG3",
    "MYBPH",
    "MYBPC1",
    "MX2",
    "APBB1IP",
    "ANPEP",
    "ALPL",
    "GPRC5A",
    "SPP1",
    "CXCL2",
    "GPC5",
    "RRAD",
    "LIF",
    "CHRNA9",
    "IL4R",
    "NPNT",
    "SAA1",
    "NPR3",
    "PROM1",
    "SLIT3",
    "ITGBL1",
    "MYO5B",
    "RPS5",
    "RPS27",
    "ETS2",
    "PTGS2",
    "RPS18",
    "BNC2",
    "CPA4",
    "NPAS2",
    "CD274",
    "SLC10A6",
    "LRAT",
    "LINC01993",
    "LINC02832",
    "LINC02821",
    "GBP5",
    "AC021851.2",
    "AKAP12",
    "LINC02154",
    "FN1",
    "MIR222HG",
    "VEGFA",
    "GBP2",
    "ZNF735",
    "TSHZ2",
    "TRPM2",
    "LUCAT1",
    "PI3"
  ],
  "programs": [
    {
      "program_name": "Mesenchymal Transition & Invasion",
      "description": "This program encompasses the transition of glioblastoma cells towards a mesenchymal, highly invasive state associated with aggressive tumor progression, therapy resistance, and poor prognosis. Gene products facilitate ECM remodeling, motility, and intratumoral heterogeneity.",
      "atomic_biological_processes": [
        {
          "name": "ECM Remodeling",
          "genes": [
            "FN1",
            "COL6A2",
            "COL1A2",
            "COL5A1",
            "TNC",
            "SPP1",
            "SERPINE1",
            "CHI3L1",
            "MMPs"
          ],
          "citation": [
            {
              "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7343887/",
              "source_id": "",
              "notes": "Comprehensive review of invasion mechanisms in glioblastoma highlighting ECM gene contributions."
            }
          ]
        },
        {
          "name": "Mesenchymal Marker Upregulation",
          "genes": [
            "CHI3L1",
            "SPP1",
            "FOSL1",
            "BIRC3",
            "MET",
            "AXL",
            "CAV1",
            "HMGA2"
          ],
          "citation": [
            {
              "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3570272/",
              "source_id": "",
              "notes": "FOSL1 regulates proneural-to-mesenchymal transition in glioblastoma stem cells."
            }
          ]
        }
      ],
      "atomic_cellular_components": [
        {
          "name": "Invadosome Complex",
          "genes": [
            "CAV1",
            "FN1",
            "SERPINE1"
          ],
          "citation": [
            {
              "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9515361/",
              "source_id": "",
              "notes": "CAV1 required for invadosome formation and matrix invasion."
            }
          ]
        }
      ],
      "predicted_cellular_impact": [
        "Enhanced invasion and motility of tumor cells",
        "Promotion of therapy resistance by supporting stem-like populations",
        "ECM remodeling and increased intratumoral heterogeneity"
      ],
      "evidence_summary": "Multiple mesenchymal markers and ECM remodeling genes are co-expressed in glioblastoma, supporting aggressive invasion and resistance to therapy.",
      "significance_score": 0.97,
      "citations": [
        {
          "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7343887/",
          "source_id": ""
        },
        {
          "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3570272/",
          "source_id": ""
        }
      ],
      "supporting_genes": [
        "FN1",
        "COL6A2",
        "COL1A2",
        "COL5A1",
        "TNC",
        "SPP1",
        "SERPINE1",
        "CHI3L1",
        "FOSL1",
        "BIRC3",
        "MET",
        "AXL",
        "CAV1",
        "HMGA2"
      ],
      "required_genes_not_in_input": {
        "genes": [
          "MMP2",
          "MMP9"
        ],
        "citations": [
          {
            "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7343887/",
            "source_id": ""
          }
        ]
      }
    },
    {
      "program_name": "Hypoxia Response & Angiogenesis",
      "description": "Genes driving responses to hypoxia, neovascularization, and metabolic adaptation. Prominent in glioblastoma's enhancement of vascular networks, therapeutic resistance, and resilience in low-oxygen microenvironments.",
      "atomic_biological_processes": [
        {
          "name": "Hypoxia Response",
          "genes": [
            "SERPINE1",
            "VEGFA",
            "ANGPTL4",
            "APLN",
            "NDRG1",
            "BIRC3",
            "MET"
          ],
          "citation": [
            {
              "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7850583/",
              "source_id": "",
              "notes": "NDRG1 and metabolic adaptation to hypoxia in glioblastoma."
            }
          ]
        },
        {
          "name": "Angiogenesis",
          "genes": [
            "VEGFA",
            "CCN1",
            "ANGPTL4",
            "APLN",
            "ANPEP",
            "ICAM1"
          ],
          "citation": [
            {
              "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6571400/",
              "source_id": "",
              "notes": "Review of angiogenic programs and their genetic regulators in glioblastoma."
            }
          ]
        }
      ],
      "atomic_cellular_components": [
        {
          "name": "Blood Vessel Endothelium",
          "genes": [
            "VEGFA",
            "ANGPTL4",
            "CCN1",
            "ICAM1",
            "APLN",
            "ANPEP"
          ],
          "citation": [
            {
              "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6571400/",
              "source_id": "",
              "notes": "Details role of endothelium in glioblastoma neovascularization."
            }
          ]
        }
      ],
      "predicted_cellular_impact": [
        "Induction of angiogenesis and microvascular proliferation",
        "Cellular adaptation to hypoxia and metabolic stress",
        "Promotion of inflammation and immune cell recruitment"
      ],
      "evidence_summary": "Many program genes are direct transcriptional targets of HIF, controlling angiogenesis and metabolic adaptation in glioblastoma.",
      "significance_score": 0.95,
      "citations": [
        {
          "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6571400/",
          "source_id": ""
        },
        {
          "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7850583/",
          "source_id": ""
        }
      ],
      "supporting_genes": [
        "VEGFA",
        "ANGPTL4",
        "APLN",
        "CCN1",
        "ICAM1",
        "SERPINE1",
        "NDRG1",
        "BIRC3",
        "MET",
        "ANPEP"
      ],
      "required_genes_not_in_input": {
        "genes": [
          "HIF1A",
          "EGLN1"
        ],
        "citations": [
          {
            "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6571400/",
            "source_id": ""
          }
        ]
      }
    },
    {
      "program_name": "Immunosuppression & Inflammation",
      "description": "Genes promoting immune evasion, immunosuppressive microenvironment via cytokines, chemokines, immune checkpoints, and inflammation mediators.",
      "atomic_biological_processes": [
        {
          "name": "Cytokine and Chemokine Signaling",
          "genes": [
            "IL6",
            "CXCL10",
            "CXCL8",
            "IL1R1",
            "CXCL14",
            "PTGS2",
            "TLR2",
            "ICAM1",
            "ID01",
            "SAA1",
            "SAA2",
            "SAA4"
          ],
          "citation": [
            {
              "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6532277/",
              "source_id": "",
              "notes": "Cytokine profiles in glioblastoma and their role in immune suppression."
            }
          ]
        },
        {
          "name": "Immune Checkpoint Regulation",
          "genes": [
            "CD274",
            "BIRC3",
            "TNFAIP3",
            "IDO1",
            "FAS"
          ],
          "citation": [
            {
              "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5792576/",
              "source_id": "",
              "notes": "IDO1 as immune checkpoint and therapeutic target in GBM."
            }
          ]
        }
      ],
      "atomic_cellular_components": [
        {
          "name": "Immune Synapse",
          "genes": [
            "ICAM1",
            "CD274",
            "FAS"
          ],
          "citation": [
            {
              "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5792576/",
              "source_id": "",
              "notes": "Details immune checkpoint formation and role in glioblastoma immune evasion."
            }
          ]
        }
      ],
      "predicted_cellular_impact": [
        "Inhibition of anti-tumor immunity",
        "Recruitment of immunosuppressive macrophages and T cells",
        "Promotion of chronic inflammation tissue remodeling"
      ],
      "evidence_summary": "Cytokines and immune checkpoint proteins are key mediators of glioblastoma immunosuppression and therapy resistance.",
      "significance_score": 0.93,
      "citations": [
        {
          "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6532277/",
          "source_id": ""
        },
        {
          "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5792576/",
          "source_id": ""
        }
      ],
      "supporting_genes": [
        "IL6",
        "CXCL10",
        "CXCL8",
        "IL1R1",
        "PTGS2",
        "TLR2",
        "ICAM1",
        "CD274",
        "IDO1",
        "FAS",
        "BIRC3",
        "TNFAIP3",
        "SAA1",
        "SAA2",
        "SAA4",
        "CXCL14"
      ],
      "required_genes_not_in_input": {
        "genes": [
          "PDCD1",
          "CTLA4"
        ],
        "citations": [
          {
            "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5792576/",
            "source_id": ""
          }
        ]
      }
    },
    {
      "program_name": "Stem Cell Maintenance & Therapy Resistance",
      "description": "Genes regulating maintenance, self-renewal, and therapy resistance of glioblastoma stem-like cells, driving tumor initiation, recurrence, and resistance to cytotoxic treatment.",
      "atomic_biological_processes": [
        {
          "name": "Cancer Stem Cell Self-Renewal",
          "genes": [
            "PROM1",
            "LIF",
            "HMGA2",
            "FOSL1",
            "BIRC3",
            "MET"
          ],
          "citation": [
            {
              "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4939379/",
              "source_id": "",
              "notes": "HMGA2 and stemness in glioblastoma."
            }
          ]
        },
        {
          "name": "Therapy Resistance",
          "genes": [
            "BIRC3",
            "FOSL1",
            "MET",
            "SERPINE1"
          ],
          "citation": [
            {
              "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5439291/",
              "source_id": "",
              "notes": "BIRC3 as driver of therapeutic resistance in glioblastoma."
            }
          ]
        }
      ],
      "atomic_cellular_components": [
        {
          "name": "Stem Cell Niche",
          "genes": [
            "PROM1",
            "LIF",
            "HMGA2"
          ],
          "citation": [
            {
              "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4939379/",
              "source_id": "",
              "notes": "Stem cell niche and maintenance in glioblastoma."
            }
          ]
        }
      ],
      "predicted_cellular_impact": [
        "Promotion of tumor initiation and recurrence",
        "Resistance to cytotoxic and antiangiogenic treatments",
        "Enhanced stem cell maintenance and plasticity"
      ],
      "evidence_summary": "Stem cell regulators and resistance genes are co-expressed in glioblastoma, supporting tumor renewal and resistance to treatment.",
      "significance_score": 0.92,
      "citations": [
        {
          "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4939379/",
          "source_id": ""
        },
        {
          "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5439291/",
          "source_id": ""
        }
      ],
      "supporting_genes": [
        "PROM1",
        "LIF",
        "HMGA2",
        "FOSL1",
        "MET",
        "BIRC3",
        "SERPINE1"
      ],
      "required_genes_not_in_input": {
        "genes": [
          "SOX2",
          "NANOG"
        ],
        "citations": [
          {
            "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4939379/",
            "source_id": ""
          }
        ]
      }
    }
  ],
  "method": {
    "clustering_basis": [
      "pathway databases",
      "co-citation",
      "co-expression",
      "protein-protein interaction"
    ],
    "notes": "Gene programs identified by reviewing experimental studies and curated pathway analyses; highlighted cluster overlap and direct citation support for gene-level roles. Only programs with strong literature support or high-level emerging evidence in glioblastoma were prioritized."
  },
  "version": "2025-11-14"
}